Xebra Brands Ltd. (TSE:XBRA)
:XBRA
Top Page
No summary available
Positive Factors
Market Expansion
Entering the U.S. CBD market with a strategic partner enhances Xebra's market presence in North America, tapping into the world's largest hemp and CBD market, which is crucial for long-term growth.
Negative Factors
Financial Instability
Persistent financial instability, marked by negative cash flow and declining equity, poses a risk to Xebra's ability to sustain operations and invest in growth opportunities.
Read all positive and negative factors
Positive Factors
Negative Factors
Market Expansion
Entering the U.S. CBD market with a strategic partner enhances Xebra's market presence in North America, tapping into the world's largest hemp and CBD market, which is crucial for long-term growth.
Read all positive factors
Xebra Brands Ltd. (XBRA) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$420.72K
Dividend YieldN/A
Average Volume (3M)0.00
Price to Earnings (P/E)―
Beta (1Y)-0.51
Revenue GrowthN/A
EPS GrowthN/A
CountryCA
EmployeesN/A
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)N/A
Shares Outstanding84,144,850
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)58.81
Price to Sales (P/S)294.39
P/FCF Ratio-19.59
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Xebra Brands Ltd. Business Overview & Revenue Model
Company Description
Xebra Brands Ltd. engages in the cultivation, processing, manufacturing, design, and delivery of cannabis products in Canada. It provides cannabis infused beverages, including seltzers, soft drinks, iced teas, lemonades, waters, and energy and spo...
How the Company Makes Money
Xebra Brands Ltd. generates revenue through the cultivation, production, and sale of cannabis products. The company's primary revenue streams include the sale of cannabis flowers, oils, and infused products to both medical and recreational consume...
Xebra Brands Ltd. Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | TTM | May 2023 | May 2022 | Feb 2021 | Feb 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 0.00 | 106.86K | 158.95K | 0.00 | 0.00 |
| Gross Profit | -324.46K | -308.42K | -16.03K | -550.31K | -11.78K |
| EBITDA | -1.60M | -1.49M | -2.82M | -1.32M | -2.78M |
| Net Income | -1.97M | -1.96M | -4.02M | -1.86M | -2.79M |
Balance Sheet | |||||
| Total Assets | 431.44K | 379.37K | 1.32M | 3.60M | 5.14M |
| Cash, Cash Equivalents and Short-Term Investments | 7.77K | 102.42K | 202.29K | 93.33K | 955.41K |
| Total Debt | 0.00 | 0.00 | 0.00 | 67.03K | 321.27K |
| Total Liabilities | 638.28K | 789.96K | 772.16K | 618.85K | 610.72K |
| Stockholders Equity | 53.67K | -154.52K | 795.67K | 3.00M | 4.54M |
Cash Flow | |||||
| Free Cash Flow | -416.82K | -827.56K | -2.39M | -1.06M | -2.28M |
| Operating Cash Flow | -416.82K | -827.56K | -2.32M | -911.32K | -1.96M |
| Investing Cash Flow | 0.00 | 0.00 | -63.63K | -145.28K | -1.57M |
| Financing Cash Flow | 322.33K | 722.64K | 1.94M | 201.60K | 4.48M |
Xebra Brands Ltd. Technical Analysis
Negative
0.01
Price Trends
<0.01
Positive
<0.01
Positive
0.01
Negative
Market Momentum
>-0.01
Negative
32.35
Neutral
100.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:XBRA, the sentiment is Negative. The current price of 0.01 is above the 20-day moving average (MA) of <0.01, above the 50-day MA of <0.01, and below the 200-day MA of 0.01, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 32.35 is Neutral, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:XBRA.
Xebra Brands Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
TSE:XBRA
Xebra Brands Ltd.
0.01
-0.07
-87.50%
TSE:MLCL
Molecule Holdings
0.01
0.00
0.00%
TSE:GHG
Global Hemp
0.02
0.00
0.00%
TSE:LOWL
Lowell Farms
0.02
-0.03
-62.50%
TSE:CNTR
CENTR Brands
0.04
-0.01
-20.00%
TSE:XCX
Greenrise Global Brands Inc
0.01
-0.01
-50.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―